CHRW
56
-3
AVY
53
3
PSA
58
2
AAP
24
6
A
43
2
HAS
33
3
BF.B
33
2
ADT
53
3
ES
34
3
NEE
50
-5
HSIC
56
5
WDC
47
4
FDX
43
3
UPS
60
9
DHI
48
4
CTSH
56
2
FE
50
-2
CCI
31
3
LB
63
22
NVDA
56
-4
CHRW
56
-3
AVY
53
3
PSA
58
2
AAP
24
6
A
43
2
HAS
33
3
BF.B
33
2
ADT
53
3
ES
34
3
NEE
50
-5
HSIC
56
5
WDC
47
4
FDX
43
3
UPS
60
9
DHI
48
4
CTSH
56
2
FE
50
-2
CCI
31
3
LB
63
22
NVDA
56
-4
Financhill
Back

Viking Therapeutics 10K Form

Sell
38

VKTX
Viking Therapeutics

Last Price:
52.62
Seasonality Move:
50.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VKTX News And Ratings

See the #1 stock for the next 7 days that we like better than VKTX

VKTX Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-21.96M
Price / Cash Flow: 0
Annual Sales: $8.18
Price / Book: 6.43

Profitability

EPS (TTM): -0.93000
Net Income (TTM): $-99.15M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Viking Therapeutics Earnings Forecast

Key Viking Therapeutics Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

Viking Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VKTX
CUSIP: 92686J
Website: vikingtherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VKTX Technical Analysis vs Fundamental Analysis

Sell
38
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy or a Sell?